Who owns Travere Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TVTX from SEC Form 13F filings across 345 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 345 institutions disclosed 110.5M shares of Travere Therapeutics, Inc. worth $6.51B — about 116.8% of shares outstanding; the largest disclosed holder is Janus Henderson Group Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
345
13F holders
$6.51B
value, 2026 filers
116.8%
of shares outstanding (110.5M sh)
63
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TVTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd.NEW | 11.9M | $700.1M | 0.3% | 12.6% | new |
| 2 | BlackRock, Inc. | 8.7M | $510.7M | 0.0% | 9.2% | +8.1% |
| 3 | FMR LLC | 5.9M | $345.5M | 0.0% | 6.2% | -17.3% |
| 4 | BANK OF AMERICA CORP /DE/ | 5.8M | $342.9M | 0.0% | 6.2% | +27.5% |
| 5 | STATE STREET CORP | 4.4M | $258.3M | 0.0% | 4.6% | +3.1% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $246.9M | 0.0% | 4.4% | +2.0% |
| 7 | PERCEPTIVE ADVISORS LLC | 3.5M | $208.6M | 3.6% | 3.7% | -5.6% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.0M | $179.0M | 0.0% | 3.2% | +97.2% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $142.5M | 0.0% | 2.6% | +2.0% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.4M | $141.9M | 0.2% | 2.5% | -6.2% |
| 11 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.2M | $131.9M | 0.1% | 2.4% | -20.4% |
| 12 | Rock Springs Capital Management LP | 2.2M | $129.8M | 7.0% | 2.3% | +1.1% |
| 13 | Kynam Capital Management, LP | 2.0M | $117.8M | 6.5% | 2.1% | 0.0% |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.9M | $110.8M | 0.0% | 2% | +42.7% |
| 15 | Stephens Investment Management Group LLC | 1.9M | $110.5M | 1.2% | 2% | +0.1% |
| 16 | GOLDMAN SACHS GROUP INC | 1.8M | $106.4M | 0.0% | 1.9% | +17.7% |
| 17 | WELLINGTON MANAGEMENT GROUP LLP | 1.6M | $93.0M | 0.0% | 1.7% | +3.0% |
| 18 | EMERALD ADVISERS, LLC | 1.6M | $92.1M | 2.5% | 1.7% | -2.3% |
| 19 | Driehaus Capital Management LLC | 1.5M | $90.3M | 0.6% | 1.6% | +6.5% |
| 20 | ARMISTICE CAPITAL, LLC | 1.3M | $75.9M | 0.9% | 1.4% | -18.0% |
| 21 | ORBIMED ADVISORS LLC | 1.2M | $70.7M | 1.3% | 1.3% | +374.5% |
| 22 | Qube Research & Technologies Ltd | 1.2M | $69.0M | 0.1% | 1.2% | -18.8% |
| 23 | Assenagon Asset Management S.A. | 1.1M | $67.4M | 0.1% | 1.2% | +168.1% |
| 24 | MPM BIOIMPACT LLC | 1.1M | $64.1M | 4.8% | 1.2% | -3.1% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 1.1M | $63.5M | 0.1% | 1.1% | -41.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.